Isabel De Paoli drives organizational transformation and strategic growth across the global healthcare landscape by aligning top-tier leadership with high-performing team dynamics. As a consultant in the Healthcare Practice, she leverages extensive executive leadership and investment experience to advise C-suite leaders and boards on complex transformations, capital allocation, organizational design and leadership effectiveness. Isabel’s area of healthcare expertise spans life sciences, pharma, pharma services and med tech, and she’s well-versed at working with private equity professionals in assessing leadership challenges in healthcare.
Dedicated to helping companies navigate the pressures of deep transformations, including artificial intelligence integration, intensifying international competition and shifting global markets, Isabel focuses on identifying and developing elite talent to secure long-term competitive advantages. She believes that great leadership and teams are the differentiating factors to drive progress and innovation in healthcare at scale.
Discovering and building exceptional healthcare leadership teams
- Previously, Isabel served as executive vice president and chief strategy officer for Merck, where she directed group-wide transformation programs, capital allocation strategies and the buildup of deep-tech business platforms.
- She has been a partner in private capital with EQT Partners within the healthcare sector, leading all aspects of investment and value-creation with portfolio companies.
- Earlier in her career, Isabel gained experience in private equity as an investment manager at Permira Beteiligungsberatung GmbH as well as a management consultant at Boston Consulting Group.
Isabel holds a Chemical Engineering Diploma from the State University of Campinas and a Master of Science in process engineering from the Technical University Hamburg-Harburg. She also completed a professional management program at the Northern Institute of Technology.